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Abstract: Background: Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative 
disease of the motor neurons. The etiology of ALS remains largely unknown, particularly with 
reference to the potential environmental determinants. Methods: We performed a population-based 
case-control study in four provinces from both Northern and Southern Italy in order to assess non-
genetic ALS risk factors by collecting through tailored questionnaires information about clinical and 
lifestyle factors. We estimated ALS risk by calculating odds ratio (OR) with its 95% confidence 
interval (CI) using unconditional logistic regression models adjusted for sex, age and educational 
attainment. Results: We recruited 230 participants (95 cases and 135 controls). We found a possible 
positive association of ALS risk with trauma, particularly head trauma (OR = 2.61, 95% CI 1.19–5.72), 
electric shock (OR = 2.09, 95% CI 0.62–7.06), and some sports, although at a competitive level only. 
In addition, our results suggest an increased risk for subjects reporting use of private wells for 
drinking water (OR = 1.38, 95% CI 0.73–2.27) and for use of herbicides during gardening (OR = 1.95, 
95% CI 0.88–2.27). Conversely, there was a suggestion of an inverse association with overall fish 
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consumption (OR = 0.27, 95% CI 0.12–0.60), but with no dose-response relation. Consumption of 
some dietary supplements, namely those containing amino acids and, in the Southern Italy 
population, vitamins and minerals such as selenium, seemed associated with a statistically 
imprecise increased risk. Conclusions: Our results suggest a potential etiologic role a number of 
clinical and lifestyle factors with ALS risk. However, caution is needed due to some study 
limitations. These include the small sample size and the low number of exposed subjects, which 
affect statistical precision of risk estimates, the potential for exposure misclassification, and the 
uncertainties about mechanisms underpinning the possible association between these factors and 
disease risk. 
Keywords: amyotrophic lateral sclerosis; case-control study; environmental factors; trauma; diet 
 
1. Introduction 
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects both upper and 
lower motor neurons. Disease progression is generally rapid and, after substantial respiratory and 
nutritional failure, leads to death in 70–80% of affected individuals within 5 years [1–3]. The 
worldwide prevalence of ALS is approximately 6 cases per 100,000 individuals [4], while annual 
incidence varies worldwide from approximately 1 to 2.6 cases per 100,000 individuals. In terms of 
geographical distribution, incidence is higher in populations of European than Asian origin [5]. An 
increase in ALS incidence has been reported in recent decades [6], in Italy as well [7–11]. Despite 
progress in assessing the role of genetic factors [12], the etiology of ALS remains largely unknown. 
To date, the only recognized risk factors are male sex, older age and a family history of ALS, which 
is frequently associated with specific gene mutations [13]. Many putative exogenous factors have 
been investigated, including exposure to pesticides, electromagnetic fields, some metals, 
cyanobacteria contamination, as well as a history of medical conditions and lifestyle choices [14–19]. 
Nevertheless, a definite environmental risk factor has not been identified so far. In the present study, 
we aimed at investigating the association between clinical history, lifestyles, and other personal 
characteristics with the risk of ALS using a large population-based case-control study in four Italian 
provinces. 
2. Methods 
Subsequent to approval by the Ethics Committees of Catania, Modena and Reggio Emilia (no. 
80/11), and Novara (no. 4/12), we designed a population-based case-control study to investigate the 
role of clinical and environmental factors in the etiology of ALS. We attempted to recruit all sporadic 
ALS cases diagnosed in the period 2008–2011 in the provinces of Catania, Modena, and Reggio Emilia, 
and in the period 2002–2012 in Novara province. 
We used multiple sources for the identification of eligible cases: the Emilia-Romagna Registry 
for ALS (ERRALS, established in 2009), and the Piedmont and Valle d’Aosta Register for ALS 
(PARALS, established in 1995), including hospital discharge records for the entire study period, death 
certificate files, and the drug prescription directories of Emilia-Romagna, Piedmont and Sicily. We 
only included in the study patients diagnosed with ‘definite’ and ‘probable’ ALS based on the El 
Escorial revised criteria. We therefore excluded familial cases [20]. Finally, we tested cases for repeat 
expansions in the C9orf72 gene. 
Using the National Health Service directory of the residents in the study provinces, we randomly 
selected controls from four populations, matched by sex, age (+/−5) and province of residence. We 
recruited cases either at the Neurology Units of the study area or by contacting them by phone and/or 
regular-mail. Study materials included an information leaflet with the description of study aim, 
methods and contact details of the study investigators, the informed consent form, the questionnaire, 
and a prepaid return envelope for those contacted by mail. 
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We estimated ALS risk by calculating the disease odds ratio (OR) and 95 % confidence intervals 
(CI) in crude and adjusted unconditional logistic regression models. We included sex, age, and 
educational attainment as potential confounders in the multivariable model. We also performed 
stratified analysis by sex and geographic area (Southern versus Northern Italy, i.e., the Catania 
province as opposed to remaining provinces). We used Stata Software (v16.1, Stata Corp, College 
Station, TX, USA, 2019) for all data analysis. 
3. Results 
Table 1 shows the characteristics of the 230 participants who accepted to participate in the study. 
The average response rate was 19.0% (230/1211), higher in Emilia-Romagna (122/462 = 24.6%), 
followed by Piedmont (68/337 = 20.2%) and Sicily (40/412 = 9.7%).  
Table 1. Characteristics of study population. 
Characteristics Cases 
n (%) 
Controls 
n (%) 
Total 
n (%) 
All subjects 95 (100) 135 (100) 230 (100) 
Sex    
Men 51 (53.7) 71 (52.6) 122 (53.0) 
Women 44 (46.3) 64 (47.4) 108 (47.0) 
Age    
Mean (SD) years 64.9 (11.7) 66.5 (10.3) 65.8 (10.9) 
< 65 years 46 (48.4) 56 (41.5) 102 (44.3) 
≥ 65 years 49 (51.6) 79 (58.5) 128 (55.6) 
Province of residence    
Catania 19 (20.0) 21 (15.6) 40 (17.4) 
Modena 29 (30.5) 47 (34.8) 76 (33.0) 
Reggio Emilia 13 (13.7) 33 (24.4) 46 (20.0) 
Novara 34 (37.8) 34 (25.2) 68 (29.6) 
Educational attainment    
Primary school or less 40 (42.1) 47 (34.8) 87 (37.8) 
Middle school 24 (25.3) 28 (20.7) 52 (22.6) 
High school 23 (24.2) 42 (31.1) 65 (28.3) 
College or higher 8 (8.4) 18 (13.3) 26 (11.3) 
Marital status    
Married 64 (67.4) 101 (74.8) 165 (71.7) 
Unmarried 9 (9.5) 8 (5.9) 17 (7.4) 
Previously married 22 (23.2) 26 (19.3) 48 (20.9) 
Occupational sector    
Agriculture 9 (9.5) 8 (5.9) 17 (7.4) 
Manufacturing 48 (50.5) 55 (40.7) 103 (44.8) 
Services 38 (40.0) 72 (53.3) 110 (47.8) 
Handedness    
Right dominant 83 (87.4) 124 (91.8) 207 (90.0) 
Left dominant 4 (4.2) 4 (2.9) 8 (3.5) 
Ambidextrous 8 (8.4) 7 (5.2) 15 (6.5) 
Footedness    
Right dominant 83 (87.4) 123 (91.1) 206 (89.6) 
Left dominant 11 (11.6) 10 (7.4) 21 (9.1) 
Ambidextrous 1 (1.0) 2 (1.5) 3 (1.3) 
ALS cases in the family    
Yes 5 (5.3) 2 (1.5) 7 (3.0)  
No 90 (94.7) 133 (98.5) 233 (97.0) 
ALS: Amyotrophic lateral sclerosis. 
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Overall, we recruited 95 (men/women: 51/44) cases and 135 controls (men/women: 71/64). Mean 
age was 65.8 years (standard deviation: 10.9), slightly higher in cases. As regards educational 
attainment, a higher proportion of controls graduated at high school or higher than cases, while 
controls showed a lower proportion of unmarried and previously married participants. Five cases 
and two controls reported at least one relative within the second grade with an ALS diagnosis. Six 
cases revealed a repeat expansion mutation in the C9orf72 gene, and two of them also reported an 
ALS diagnosis in the family. The majority of subjects were right-dominant handed and footed, while 
a few participants reported to be left-dominant or ambidextrous. The distribution of sites of ALS 
onset is reported in Table 2 according to handedness and footedness of cases. We found that right 
dominant handed cases have a slightly higher percentage of bulbar onset compared to non-right 
dominant handed. While we found no substantial difference in right or left-limb onset according to 
handedness, a higher percentage of contralateral onset for non-right dominant footed participants 
was noted. In addition, all cases with bulbar onset were right-dominant footed. When we divided 
sites according to lower or upper limb onset, we found a substantially comparable distribution across 
right and left handed/footed cases. 
Table 2. Distribution of ALS onset sites according to handedness and footedness (divided into right 
and non-right dominant). 
Type of onset 
Right 
Handed 
Dominant 
Non-Right 
Handed 
Dominant 
Right 
Footed 
Dominant 
Non-Right 
Footed 
Dominant 
Total 
n (%) 
Laterality of onset      
Bilateral onset 16 (19.3) 3 (15.0) 16 (19.3) 3 (25.0) 19 (20.0) 
Right-limb onset 26 (31.3) 4 (33.3) 24 (28.9) 6 (50.0) 30 (31.6) 
Left-limb onset 10 (12.0) 2 (16.7) 11 (13.2) 1 (8.3) 12 (12.6) 
Bulbar 25 (30.1) 2 (16.7) 27 (32.5) 0 (0.0) 27 (28.4) 
Other/trunk 6 (7.2) 1 (8.3) 5 (6.2) 2 (16.7) 7 (7.4) 
Upper/lower onset      
Upper limb onset 22 (26.5) 3 (25.0) 22 (26.5) 3 (25.0) 25 (26.3) 
Right upper limb onset 15 (18.1) 2 (16.7) 15 (18.1) 2 (16.7) 17 (17.9) 
Left upper limb onset 7 (8.4) 1 (8.3) 7 (8.4) 1 (8.3) 8 (8.4) 
Lower limb onset 10 (12.0) 1 (8.3) 10 (12.0) 1 (8.3) 11 (11.6) 
Right lower limb onset 8 (9.6) 0 (0.0) 7 (8.4) 0 (0.0) 7 (8.4) 
Left lower limb onset 2 (2.4) 1 (8.3) 3 (2.4) 1 (8.3) 4 (4.2) 
Bulbar 16 (19.3) 2 (16.7) 18 (21.7) 0 (0.0) 18 (18.9) 
Mixed upper/lower right 3 (3.6) 1 (8.3) 2 (16.7) 2 (16.7) 4 (4.2) 
Mixed upper/lower left 11 (13.2) 3 (25.0) 12 (14.5) 2 (16.7) 14 (14.7) 
Other/trunk 21 (25.3) 2 (16.7) 19 (22.9) 4 (33.3) 23 (24.2) 
Table 3 shows the association between potential risk factors and ALS. In the analysis of dominant 
handedness and footedness, we found a positive association between ALS and both non-right 
dominant handed and footed subjects.  
Table 3. Odds ratio (OR) with 95% confidence interval (CI) of ALS risk according to personal 
characteristics and clinical factors. 
Factors Cases (y/n) 
Controls 
(y/n) OR 
a OR b (95% CI) 
Personal information and habits      
Dominant hand      
Right-handed 83 124 Ref.   
Left-handed 4 4 1.49 1.45 (0.34–6.14) 
Ambidextrous 8 7 1.71 1.73 (0.59–5.02) 
Non-right handed 12/83 11/124 1.63 1.63 (0.67–3.92) 
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Table 3. Cont. 
Dominant foot      
Right 85 123 Ref.   
Left 11 10 1.63 1.62 (0.64–4.06) 
Ambidextrous 2 1 0.74 0.78 (0.07–8.84) 
Non-right  12/83 12/123 1.48 1.47 (0.62–3.50) 
Regular use of skin cream c 25/43 66/68 0.60 0.53 (0.27–1.06) 
Having or ever having had amalgam 
fillings c 42/26 79/55 1.12 1.17 (0.62–2.20) 
Regular use of chewing gum c 16/52 18/116 1.99 2.09 (0.92–4.74) 
Eat fish c 48/20 120/14 0.28 0.27 (0.12–0.60) 
Eat ≥3 fish-based meals per week c 6/62 18/116 0.62 0.58 (0.22–1.58) 
Wine drinking c 43/52 85/50 0.49 0.46 (0.26–0.82) 
Alcohol units intake c,d 10/58 21/113 0.93 0.98 (0.42–2.28) 
Main source of drinking water      
No preference 34 46 Ref. Ref.  
Municipal water 24 55 0.59 0.55 (0.28–1.07) 
Private wells 4 3 1.80 1.44 (0.29–7.03) 
Bottled water 33 31 1.44 1.24 (0.62–2.44) 
Current use of any private well water 12/83 9/126 2.02 1.91 (0.76–4.79) 
Ever use a private well/fountain for 
drinking water 38/57 46/89 1.29 1.38 (0.73–2.27) 
Current use of a private well/fountain 
for irrigation 14/81 30/105 0.60 0.57 (0.28–1.16) 
Ever smoking 49/46 65/70 1.15 1.19 (0.68–2.09) 
Current smoking 11/84 15/112 1.05 1.00 (0.42–2.35) 
Use of the following dietary 
supplements in the former 20 years: 26/69 46/89 0.73 0.70 (0.39–1.25) 
Vitamin supplements 17/78 29/106 0.80 0.80 (0.40–1.59) 
Vitamin and mineral supplements 16/79 27/108 0.81 0.73 (0.36–1.47) 
Aminoacidic supplements 4/91 2/133 2.92 2.81 (0.47–16.87) 
Energy drinks 7/88 11/124 0.90 0.88 (0.31–2.51) 
Selenium-containing supplements 23/72 37/98 0.85 0.88 (0.47–1.65) 
Clinical history      
Any trauma requesting medical 
evaluation 35/60 49/86 1.02 1.14 (0.64–2.01) 
Head trauma 19/76 13/122 2.35 2.61 (1.19–5.72) 
Trunk trauma 9/86 8/127 1.66 1.76 (0.64–4.85) 
Arm trauma 16/79 39/96 0.50 0.52 (0.27–1.02) 
Any fracture 34/61 54/81 0.84 0.85 (0.49–1.48) 
Head fracture 3/92 1/134 4.37 4.07 (0.40–41.30) 
Trunk fracture 6/89 10/125 0.84 0.93 (0.31–2.73) 
Arm fracture 26/69 45/90 0.75 0.75 (0.41–1.35) 
Electric shock trauma 7/88 5/130 2.07 2.09 (0.62–7.06) 
Previous Polio vaccine 41/54 66/69 0.79 0.75 (0.41–1.35) 
Previous spinal anesthesia 24/71 36/99 0.93 0.94 (0.51–1.74) 
Ever been blood donor 24/71 37/98 0.90 0.98 (0.53–1.84) 
Any surgery 76/19 113/22 0.78 0.75 (0.37–1.53) 
with general anesthesia 23/53 35/78 0.97 0.97 (0.51–1.85) 
ALS cases in the family 5/90 2/133 3.69 3.56 (0.65–19.45) 
a Crude model; b Model adjusted by sex, age, and educational attainment; c Section missing for 28 
subjects due to pilot version of the questionnaire. Analysis performed in 202 participants only (68 
cases/134 controls); d Recommended alcohol units (two alcohol units in men, one unit in women) used 
as cutoff points. 
With a view to personal habits, we found an inverse association between risk and regular fish 
consumption (OR = 0.27, 95% CI 0.12–0.60). However, There was no evidence of a dose-response 
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association because an intake equal to or higher than 3 times per week was required to show an OR 
of 0.58 (95% CI 0.22–1.58). Similarly, any wine consumption was inversely associated with ALS (OR 
= 0.46, 95% CI 0.26–0.82), whilst consumption of alcohol units higher than recommended (>2 alcohol 
units/day in men and >1/day unit in women) was not associated with disease risk. Use of private 
wells as a main source (≥70%) of drinking water showed a positive association compared with 
municipal tap water (OR = 1.44, 95% CI 0.29–7.03), along with the use of a private well as a source of 
drinking water (OR = 1.38, 95% CI 0.73–2.27). History of dietary supplements use in the past 20 years 
showed a virtually null association with the disease, although we found a higher ALS risk in the few 
subjects reporting use of amino acid supplements (OR = 2.81, 95% CI 0.47–16.87). Finally, while 
current smoking showed no association with ALS risk, history of ever smoking showed a positive 
though imprecise association (OR = 1.19, 95% CI 0.68–2.09). 
As far as clinical history is concerned, a positive history of any trauma requesting medical 
evaluation showed a very loose association (OR = 1.14, 95% CI 0.64–2.01), but further stratified 
analysis demonstrated a positive association with head trauma (OR = 2.61, 95% CI 1.19–5.72), and 
partially with trunk trauma (OR = 1.76, 95% CI 0.64–4.85). Similarly, only head fracture seems 
positively associated with ALS, however based on its occurrence in 3 cases and 1 control only. We 
found no change in disease risk for a history of polio vaccine, blood donation, any surgery, including 
in those who had undergone general anesthesia. Finally, we found a higher risk for subjects reporting 
a positive history of ALS in the family (OR = 3.56, 95% CI 0.65–19.45). 
We found a limited difference in risk for leisure activities (Table 4), alongside a positive 
association with use of herbicides during gardening, model making, and an inverse association with 
photograph darkroom printing. As for sports, playing any sport showed a slightly inverse association 
(OR = 0.77, 95% CI 0.41–1.42) including those at a competitive level. A slightly increased risk was 
associated with soccer at a competitive level (OR = 1.19, 95% IC 0.35–4.02), skiing (OR = 1.48, 95% CI 
0.42–5.13), and marginally with swimming (OR = 1.61, 95% 0.09–27.33) due the very low number of 
exposed subjects. Sensitivity analysis after exclusion of subjects with a positive family history of ALS 
yielded substantially comparable results (Tables S1–S2). Stratified analysis carried out in men and 
women separately showed substantially comparable results with some exceptions (Tables S3–S6). In 
particular, we found a higher risk for use of amalgam fillings in men but not in women, as well as for 
the use of private wells for drinking water and for use of selenium-containing supplements. 
Conversely, ever smoking posed a higher risk in women, along with the consumption of more alcohol 
units than recommended (Tables S3–S4). In addition, we found higher estimates in men compared to 
women for any trauma, particularly head trauma, and any fracture. In relation to sports, a positive 
association was found with skiing in men, and with swimming in women, which was not evident 
from the overall analysis (Tables S5–S6). Finally, in stratified analyses according to study area, i.e., 
Northern and Southern Italy, we noted a very high risk for ever smoking in the Southern but not in 
the Northern Italian population, as was the case for use of amalgam fillings (Tables S7–S8). Similarly, 
use of private wells for drinking water was clearly associated with ALS risk in the Northern Italian 
population. On the other hand, we found a weaker association in the Southern Italian population, 
which in turn demonstrated a higher risk for use of private wells for irrigation (Tables S7–S8). As 
concerns use of dietary supplements, interestingly, an increased risk emerged in the Catania 
population for the use of vitamin and mineral supplements, and for selenium-containing 
supplements. In addition, data indicated a higher risk for trauma, head trauma, and a history of 
general or spinal anesthesia, as compared to the Northern Italy population (Table S8). With regard to 
leisure activities, we found an increased risk for gardening and painting in the Catania population, 
while we found a positive association with ALS for pesticides and herbicides use for Northern Italy 
(Tables S9–S10). We finally repeated all study analyses by excluding cases carrying the C9orf72 gene 
mutation (Tables S11–S12). No major change in strength and direction of relative risk estimates 
occurred in the analysis restricted to subjects without such gene mutation. 
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Table 4. Odds ratio (OR) with 95% confidence interval (CI) of ALS risk according to leisure activities 
and other lifestyle factors. 
Factor 
Cases 
(y/n) 
Controls 
(y/n) OR 
a OR b (95% CI) 
Hunting 4/91 6/129 0.95 1.05 (0.27–4.09) 
Fishing 20/75 37/98 0.71 0.60 (0.29–1.24) 
Using lead 16/79 32/103 0.65 0.57 (0.27–1.22) 
Using lead in fishermen only 16/4 32/5 0.62 0.86 (0.15–4.75) 
Painting 6/89 13/122 0.63 0.70 (0.25–1.98) 
Use of oil paints 2/93 8/127 0.34 0.39 (0.08–1.96) 
Use of oil paints in painters only 2/4 8/5 0.31 0.43 (0.04–4.90) 
Model-making 7/88 8/127 1.26 1.39 (0.47–4.15) 
Gardening 42/53 65/70 0.85 0.95 (0.55–1.64) 
Any use of pesticides? 20/75 28/107 1.02 1.06 (0.55–2.05) 
Using pesticides for gardening? 16/79 21/114 1.10 1.15 (0.56–2.39) 
Using herbicides for gardening? 16/79 13/122 1.90 1.95 (0.88–4.36) 
Using fungicides for gardening? 7/88 12/123 0.82 0.93 (0.35–2.51) 
Photograph darkroom printing? 5/90 24/111 0.26 0.24 (0.09–0.70) 
Play Sports 38/57 63/72 0.76 0.77 (0.41–1.42) 
Competitive sports 10/85 22/113 0.60 0.50 (0.22–1.17) 
Soccer 14/81 21/114 0.94 0.75 (0.33–1.72) 
Competitive soccer 6/89 6/129 1.45 1.19 (0.35–4.02) 
Volleyball 5/90 11/124 0.63 0.59 (0.19–1.87) 
Competitive volleyball 1/94 4/131 0.35 0.28 (0.03–2.64) 
Cycling 5/90 7/128 1.02 1.00 (0.29–3.44) 
Competitive cycling 1/94 5/131 0.35 0.31 (0.03–2.94) 
Swimming 5/90 7/128 1.02 1.12 (0.31–4.06) 
Competitive swimming 1/94 1/134 1.43 1.61 (0.09–27.33) 
Skiing 5/90 7/128 1.02 1.48 (0.42–5.13) 
Competitive skiing 0/95 0/135 - -  
Athletics 7/88 16/119 0.59 0.66 (0.25–1.74) 
Competitive athletics 0/95 6/129 - -  
Tennis 4/94 7/128 0.80 0.96 (0.26–3.53) 
Competitive tennis 1/94 0/135 - -  
a Crude model; b Model adjusted by sex, age, and educational attainment. 
4. Discussion 
Epidemiological investigations have suggested associations between ALS and a large number of 
environmental risk factors. However, evidence for each of them is still inadequate and inconsistent 
[21–23]. In this study, we investigated whether some of these potential environmental risk factors 
may play a role in the onset of sporadic ALS in four Italian populations from different areas of the 
country. 
Interestingly, we observed an inverse association with fish consumption when we compared no 
consumption with regular consumption and used three or more fish-based meals as cutoff point. 
Nonetheless, no evidence of a dose-response relation emerged, and the association was considerably 
weaker in women than in men. A large cohort study carried out in the US investigating the role of 
dietary factors failed to confirm the association with fish intake [24], while another study carried out 
in Italy reported a decreased risk only in the highest quartile compared to the lowest [25]. A pooled 
analysis of five prospective US studies suggested a protective role for foods high in omega-6 and 
omega-3 long-chain polyunsaturated fatty acids [26]. These contrasting results may be due to the 
heterogeneity behind fish consumption, i.e., lake versus sea fish, kind of and relationship with 
possible contaminants [27]. 
We found a positive association between disease risk and use of private wells for drinking water 
but not for cultivation. This was the case despite the low number of exposed subjects and the fact that 
the association seems limited to men, which strongly reduces the reliability of our results. Previous 
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studies have already suggested a positive association with the percentage of the population using 
well water and mortality rates for motor neuron diseases [28,29], possibly linked to fungal or bacterial 
contamination [30,31]. This mainly applies to cyanobacteria due to production of β-N-methylamino-
L-alanine (BMAA), a neurotoxin that may enter the food chain [31–34]. Interestingly, other findings 
linked ALS with living near lakes with the presence of algal bloom [35,36]. However, we did not 
assess water contamination through sample analysis, thus hampering the possible link with a specific 
biological agent. It is noteworthy that a previous cohort study reported an increased risk of ALS 
associated with exposure to inorganic hexavalent selenium through municipal tap water [37,38]. In 
this study, however, we found that use of drinking water from municipal utilities is associated with 
lower ALS risk compared with the use of either municipal or bottled water. While selenium content 
of municipal tap water in Italy is usually negligible, its levels in bottled and particularly well water 
may vary considerably [39,40], and further investigation about the role of this or other elements in 
raising ALS risk through exposure via drinking water is definitely required [41]. Possible differences 
in well water contamination may also explain the stronger association we found for the Northern 
Italy population compared to the Southern one, a difference which warrants further investigation. 
As regards alcohol intake, although our results indicated an inverse association between wine 
or alcohol consumption and ALS, consistent with other reports [25,42,43], null [44] and positive 
associations [26,45] have also been described. In addition, considering the adverse effects of alcohol, 
we carried out an analysis using recommended alcohol units as cutoff points. Overall, we found no 
difference in risk in participants, with a possible higher risk in women, suggesting caution in 
considering wine or alcohol to be either protective from risk factors for ALS. 
The positive association we found between ALS and smoking habits is consistent with previous 
studies [42,45–53]. Despite a few studies reporting no difference or a decreasing risk in association 
with smoking [43,54,55], nevertheless, a detrimental effect of smoking has also been reported as a 
negative prognostic factor [56,57]. This strengths the relevance of quitting in either preventing the 
onset or delaying the progression of the disease. 
As far as dominant handedness and site of onset are concerned, we found no concordance 
between dominant handedness and ipsilateral onset. Conversely, a higher percentage of cases 
signaled an upper-limb onset compared to lower limb onset. Our findings contrast with those from 
a previous study reporting a concordance between handedness and side of onset in upper limb onset 
patients [58]. Conversely, we found similar results in terms of absence of concordance between 
footedness and side of onset [58,59]. Potential reasons for such a difference in site of onset have been 
derived from the greater connectivity in the dominant motor cortex with respect to handedness [60]. 
This difference in excitability of dominant and non-dominant hemispheres [61] may be relevant to 
disease onset, due to the neuronal hyperexcitability occurring in the cortex during early stages of ALS 
[62,63]. A similar explanation was suggested for the higher risk of upper-limb as opposed to lower-
limb onset. 
With regard to dietary supplements, we found contrasting results. Although there were a low 
number of exposed subjects in such categories, only use of amino acid supplements showed a positive 
association with disease risk, while null/inverse relations could be noted for other supplements. It is 
noteworthy that a few investigations reported an inverse association with vitamin E supplements 
[64,65], but no significant associations were found for vitamin C or multivitamins use [65], consistent 
with our study. Interestingly, with reference to the positive association with use of amino acid 
compounds, an experimental study has shown that β-N-methylamino-L-alanine (BMAA), previously 
mentioned with regard to cyanobacteria bloom neurotoxicity [33], and the supplement β-alanine 
have similar and substantial comparable toxicity, despite their low levels [66]. In addition, a side 
effect of β-alanine supplementation is paresthesia (tingling) [67], suggesting caution in its 
administration, at least at high doses, within dietary supplements [68]. 
The hypothesis that trauma increases ALS risk has been suggested by several studies [43,69–74], 
with specific reference to head trauma [42,75–80], and column and trunk trauma [81,82]. However, 
inconsistent results have been reported by other studies [83–86]. One possible explanation for the 
increased ALS risk after traumatic events could be the inclusion of subjects as ALS cases who were 
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affected by chronic traumatic encephalomyelopathy associated with motor neuron disease. This 
might have been confused with ALS, especially in older studies [13,87]. In our study, however, only 
‘definite’ and ‘probable’ ALS cases were recruited, thus ruling out the occurrence of a misdiagnosis. 
Another possible explanation is that the enhanced occurrence of trauma may represent an early, 
subclinical sign of ALS onset, and may therefore be due to reverse causation [88]. However, in the 
analysis excluding head trauma over the previous five years from the date of diagnosis (N = 3 cases 
and 3 controls), we found comparable results (OR = 2.69, 95% CI 1.14–6.36). 
In our study, we found a positive yet imprecise association between previous electric shocks and 
ALS. This confirms previous observations demonstrating an increased risk [84,89–93], but not others 
showing no association [94,95]. Electrical injury may cause a wide range of morphological changes in 
the central nervous system [96], including neuronophagia, neuronal chromatolysis, neuronal loss, 
and microglial activation, which is considered an early event in central nervous system damage [97]. 
Some medical procedures have been investigated in relation to ALS risk [43,82,89,98–100]. Since 
it has been suggested that viral infections may be associated with ALS [13,84,101], we investigated 
whether polio vaccination history could be associated with disease risk. However, we found null to 
inverse association, consistent with a previous study [99]. 
In our study, we found an imprecise inverse association with overall sport playing and ALS risk, 
and limited evidence of a positive association with competitive soccer. Competitive swimming also 
showed a positive association. Nonetheless, this was statistically very imprecise and weak, based as 
it was on two exposed subjects only, suggesting extreme caution in the interpretation of these results. 
Most studies evaluating overall and individual sport playing generally showed an increased risk 
[43,53,75,77,83,102–107], although different results have also been reported [42,54,94,108–110]. 
Remarkably, our results showed an increased risk for skiers, consistent with recent findings about 
Swiss competitive players [111]. In addition, a higher incidence of ALS has been reported in 
professional athletes, especially soccer players. Thus, an attempt has been made to understand the 
role of strenuous sport and physical activity [112–114]. Exercise could alter the extent of exposure or 
could influence the distribution, metabolism or potency of an excitotoxin [115]. It has been suggested 
that a physically active lifestyle and contact sports may be particularly associated with an increased 
probability of trauma [116], especially head trauma for some sports such as soccer or football [117]. 
As for other leisure activities, we find a loose association, in line with previous studies [54,95]. The 
only exception was a marginal increase for use of pesticides during gardening, particularly 
herbicides, which appears to be consistent with previous observations [54,118,119]. 
This study has some limitations that must be acknowledged. First of all, the population-based 
design of the study, particularly with reference to the eligible controls, was associated with a low 
response rate. This reduced the overall sample size and affected the precision of the risk estimates. 
As far as cases are concerned, we acknowledge that a few deceased and seriously ill subjects may 
have not been included. In such cases, we expected that the questionnaire could be filled out by 
caregivers or other relatives. Nevertheless, when we assessed the distribution of individual 
characteristics of study cases and controls, and we compared it with that of the general population 
[120,121], only limited differences emerged. This suggests that there is little evidence of selection bias. 
In particular, the distribution of educational level in controls was comparable to the Italian 
population over 35 years based on the 2011 census data (http://dati-censimentopopolazione.istat.it/ 
Index.aspx). The limited sample size is also due to the low ALS incidence in the study areas, around 
1–2 cases/100,000 inhabitants [7,8,122,123]. 
We also acknowledge that the exposure assessment, solely based on self-report by the 
participants or their proxy respondents, could have been affected by imprecision due to the long 
period of time involved, and even by recall bias. This might have been the case especially when 
seeking long-term or historical information about former exposure to contaminants and other factors 
perceived by the cases as being associated with disease risk. In addition, the reliability and accuracy 
in recalling historical exposures dating back to several years before enrolment in the study may be 
challenged. However, we do not expect major differences between cases and controls in this matter, 
not even for differential recall bias due to the substantially limited awareness of potential risk factors 
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for ALS. Finally, the observational design of the study does not allow us to rule out the possibility 
that some unmeasured confounding may have occurred. 
Some strengths of our investigation should also be outlined. Firstly, it is worth pointing out its 
population-based design: we recruited controls from the general population, by randomly extracting 
them from Local Health Authority registries. This is mandatory for all Italian residents, thus limiting 
the occurrence of selection bias. Secondly, the study area encompassing four Italian provinces 
allowed us to increase the sample size of this case-control study, as compared with previous 
investigations. In addition, it enabled us to assess the associations under investigation in markedly 
different populations with reference to lifestyle and environmental exposures, if not genetic factors 
[124]. Finally, we were able to perform sensitivity analysis by excluding subjects reporting a history 
of ALS in their relatives or carrying the C9orf72 genetic mutation [84], in order to assess the specific 
role of environmental risk factors for sporadic ALS. Such restricted analysis yielded no substantially 
different results. 
5. Conclusions 
The results of the present case-control study suggest a possible association between some non-
genetic risk factors and ALS risk, namely trauma, particularly head trauma or fracture, electric shock, 
some competitive sport activities, use of private wells for drinking water, use of herbicides during 
gardening and consumption of some specific dietary supplements. Caution in interpreting these 
results should be used in light of the study limitations, such as the small sample size and the reduced 
statistical precision of the risk estimates, particularly when a low number of subjects are exposed, the 
potential for exposure misclassification and unmeasured confounding, and the risk of reverse 
causation due to the case-control study design. In addition, the toxicological mechanisms 
underpinning the association between the environmental factors identified in this study and disease 
risk remain to be elucidated. Therefore, further epidemiologic studies on the environmental 
determinants of ALS are clearly needed, and they should encompass a careful validation of historical 
exposures and control of potential confounders. 
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